We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

138 hedge funds and large institutions have $552M invested in Cardiovascular Systems, Inc. in 2016 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 38 increasing their positions, 34 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

283% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 12

123% more call options, than puts

Call options by funds: $958K | Put options by funds: $430K

33% more funds holding

Funds holding: 104138 (+34)

32% more capital invested

Capital invested by funds: $417M → $552M (+$135M)

12% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 34

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
138
Holders Change
+34
Holders Change %
+32.69%
% of All Funds
3.68%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
46
Increased
38
Reduced
34
Closed
12
Calls
$958K
Puts
$430K
Net Calls
+$528K
Net Calls Change
+$285K
Name Holding Trade Value Shares
Change
Change in
Stake
CCM
1
Camber Capital Management
Massachusetts
$71.2M -$24.1M -1,100,000 -27%
Wellington Management Group
2
Wellington Management Group
Massachusetts
$47.6M -$15.7M -716,273 -26%
CIP
3
Champlain Investment Partners
Vermont
$34.3M -$1.52M -69,605 -5%
Vanguard Group
4
Vanguard Group
Pennsylvania
$30.7M +$349K +15,933 +1%
GIM
5
Granahan Investment Management
Massachusetts
$26.8M +$241K +11,010 +1%
BFA
6
BlackRock Fund Advisors
California
$24.9M +$409K +18,685 +2%
D.E. Shaw & Co
7
D.E. Shaw & Co
New York
$23.2M +$3.49M +159,558 +20%
FCM
8
Frontier Capital Management
Massachusetts
$20.2M +$21.3K +974 +0.1%
BIT
9
BlackRock Institutional Trust
California
$19.5M +$323K +14,748 +2%
First Manhattan
10
First Manhattan
New York
$18.1M -$13.7M -624,005 -45%
State Street
11
State Street
Massachusetts
$13.2M +$744K +33,994 +7%
Fidelity Investments
12
Fidelity Investments
Massachusetts
$12.6M -$1.97M -90,000 -15%
PHS
13
PFM Health Sciences
California
$11.9M +$11M +502,045 New
NCGI
14
Next Century Growth Investors
Minnesota
$9.81M +$9.05M +413,187 New
Northern Trust
15
Northern Trust
Illinois
$9.51M +$183K +8,349 +2%
Millennium Management
16
Millennium Management
New York
$9.31M +$8.58M +392,029 New
CM
17
Castleark Management
Illinois
$8.42M +$7.77M +354,795 New
Invesco
18
Invesco
Georgia
$6.83M +$6.3M +287,771 New
Goldman Sachs
19
Goldman Sachs
New York
$5.73M +$5.29M +241,423 New
Two Sigma Investments
20
Two Sigma Investments
New York
$5.72M +$5.28M +241,073 New
BIM
21
Bogle Investment Management
Massachusetts
$5.72M +$1.79M +81,547 +51%
Thrivent Financial for Lutherans
22
Thrivent Financial for Lutherans
Minnesota
$5.53M +$616K +28,120 +14%
Deutsche Bank
23
Deutsche Bank
Germany
$5.48M +$4M +182,902 +382%
BC
24
Broadfin Capital
New York
$5.47M -$21.8M -996,969 -81%
NI
25
Numeric Investors
Massachusetts
$5.41M +$4.54M +207,394 +1,022%

CSII Hedge Fund Activity: Q3 2016 in Review

138 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q3 2016, worth a combined $552M — up 32% from $417M a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new CSII positions and 12 closed out — a net gain of 34 holders — while 38 added to existing stakes and 34 trimmed.

The largest buyer was PFM Health Sciences, opening a new position worth an estimated $11M. The largest seller was Camber Capital Management, cutting an estimated $24.1M.

  • 138 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q3 2016, up from 104 in Q2 2016.
  • Funds reported $552M of Cardiovascular Systems, Inc. stock for Q3 2016, up 32% quarter-over-quarter.
  • 46 funds opened new Cardiovascular Systems, Inc. positions in Q3 2016 and 12 closed out, a net change of +34 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q3 2016 was PFM Health Sciences, an estimated $11M added.
  • The largest Cardiovascular Systems, Inc. seller in Q3 2016 was Camber Capital Management, an estimated $24.1M sold.

Based on aggregated 13F filings for Q3 2016.